Analystreport

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its "strong-buy" rating re-affirmed by analysts at Raymond James.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report